Pharmacovigilance

For us, one of the key tasks is to provide consumers with high-quality, effective and safe medicines, the benefits of using which exceed possible risks.

In order to ensure control of the safety and effectiveness of medicinal products, the company operates a pharmacovigilance system in accordance with the requirements of current legislation, international standards and ethical principles of the company.

The process of pharmacovigilance begins at the stage of drug development and continues throughout its life cycle.

Timely detection of adverse side reactions and informing the regulatory authorities about them allows to carry out their analysis and, based on its results, to develop and implement in practice measures aimed at preventing the adverse consequences of drug therapy, increasing its safety, and therefore the quality of life of patients, to constantly assess the balance of in which the benefits of using our medicines outweigh the possible risks.

The message must contain the following minimum information:

• the name of the suspected medicinal product;
• a description of the adverse reaction and/or indication of lack of effectiveness;
• information about the patient who experienced an adverse reaction (name/initials, age, gender and other important information);
• contact details and information about the person providing the message (physician, patient, relative or representative of the patient).

If you wish to report the occurrence of an adverse reaction and/or lack of effectiveness during the medical use of medicinal products produced by our company, please inform the Department of Pharmacovigilance in a way convenient for you.

You can download and fill out the presented form (Message Card):

Message card for patients and/or patient representative.

Message card for medical and pharmaceutical workers.

Provide information by phone or by e-mail.

Address:

Ukraine, 24321, Ladyzhyn, Khlibozavodska St., 2

Phone:

+38 (0432) 329-249

Email:

info@enzim.biz

All information you provide is confidential and not subject to disclosure, except as required by law.